Rs 24/Share Dividend Recommended: Pharma Co Declares 29% Growth In Revenue, EPS Up 63%

Leading pharmaceuticals sector company Astrazeneca Pharma India Ltd on May 27 recommended a dividend of Rs 24/share, its highest dividend after 2005. In 2005, Astrazeneca Pharma declared its final dividend of Rs 50/share. The company witnessed stunning surge of 63% for FY 2024 in its EPS to Rs 64.6 (earning per share). Astrazeneca Pharma share offered 22% return in last 2-weeks and 101% return in last 1-year. Last trading price of Astrazeneca Pharma share on BSE is Rs 6441.05 per share. The company's market capitalisation stood at Rs 16,102.63 crore. More details below:

Astrazeneca Pharma Recommends Dividend: As per the BSE filing of the pharma company dated May 27, "We wish to inform that at the meeting of the Board of Directors of the Company held on May 27, 2024, the Board has recommended Dividend of Rs. 24/- per equity share of Rs. 2/- each, subject to the approval of Shareholders at the forthcoming Annual General Meeting of the Company. The Dividend, if approved by the Shareholders, will be credited/dispatched within 30 days from the date of Annual General Meeting of the Company."

Astrazeneca Pharma Q4 Results: AstraZeneca Pharma India Ltd achieved total revenue of INR 1,330 Cr. registering an impressive 29% growth in revenue. Revenue from Operation for financial year 2023-24 stood at INR 1,296 Cr. with substantial 29% increase. Profit Before Tax is INR 220 Cr. registering a commendable 64% growth (PBT before exceptional items at INR 201 Cr., up by 17% compared to previous financial year). Earnings Per Share (EPS) for financial year stood at INR 64.6 demonstrating a significant growth of 63%.

Dr. Sanjeev Panchal, Country President and Managing Director, AstraZeneca India, commented, " FY 2023-24 was one of the strongest years for us in the country and we take immense pride in our consistent performance. AstraZeneca India products sales for first time cross INR 1000 Cr mark, delivering total revenue of almost INR ~1300 Cr. with growth of 29% this year."

Astrazeneca Pharma Share Performance: The 52-week high price of Astrazeneca Pharma share price on BSE is Rs 7208.00 per share (as on 06/02/2024) and 52-week low price is Rs 3210.00 per share (as on 26/05/2023). Astrazeneca Pharma shares gave return of 39% in last 6-months, soared 117% in last 2-years, and surged 220% in last 5-years. In last 10-years, Astrazeneca Pharma stock soared 490%.

Astrazeneca Pharma Dividend Yield: AstraZeneca Pharma India announced 18 dividends since August 11, 2000. In last 1-year, AstraZeneca Pharma India announced an equity dividend amounting to Rs 16.00 per share. At the current share price of Rs 6441.05 per share, AstraZeneca Pharma India offers a dividend yield of 0.25%, according to Trendlyne.

Astrazeneca Pharma Stock Split History: AstraZeneca Pharma India split the face value once since June 15, 2006. AstraZeneca Pharma India last split the face value of its shares from Rs 10 to Rs 2 in 2006.The share traded ex-split as on June 15, 2006. The pharma company never recommended any bonus share.

Disclaimer: The stock highlights the dividend and is not a recommendation to buy, sell or hold. We have not done fundamental or technical analysis and have no opinion on the stock mentioned. Neither, the author nor Greynium Information Technologies should be held liable for any losses. Please consult a professional advisor.